Inventor · Paris, FR

Alain Tedgui

14Patents
1h-index
16Co-inventors
47Inventor score

Filing activity: Mar 13, 2003 → Jun 16, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US8324152B2 Composition for the treatment of atherosclerosis Emerging Cross-Sectional Technologies 2 Active
US8383355B2 Combination of sPLA2 type IIA mass and OXPL/APOB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event Physics 1 Active
US8163504B2 Combination of sPLA2 activity and OxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event Physics 1 Active
US8361732B2 Combination of sPLA2 activity and oxPL/apoB cardiovascular risk factors for the diagnosis/prognosis of a cardiovascular disease/event Physics 1 Active
US7985409B2 Tr1 cells for use in atherosclerosis Chemistry; Metallurgy 0 Expired
US8187818B2 Use of sPLA2 activity for the diagnosis of a cardiovascular event Physics 0 Active
US9193971B2 Methods for the treatment of nonalcoholic steatohepatitis Chemistry; Metallurgy 0 Active
US9592267B2 Use of IL-18BP for treatment of peripheral vascular diseases Human Necessities 0 Expired
US12144859B2 B cell depleting agent for the treatment of atherosclerosis Chemistry; Metallurgy 0 Active
US8586822B2 Methods for producing a non human model for aortic aneurysm Human Necessities 0 Active
US11752131B2 Methods and pharmaceutical compositions for the treatment of obesity Human Necessities 0 Active
US9688767B2 Method of predicting survival time in myocardial infarction patients by measuring BAFF levels Physics 0 Active
US9573997B2 Method for use in the treatment of aneurysm Chemistry; Metallurgy 0 Active
US9566313B2 Method of treating peripheral vascular diseases using IL-18 inhibitors Human Necessities 0 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.